[68Ga]Ga-FAPI-46
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for [68Ga]Ga-FAPI-46, covering 2025-05-20 to 2026-04-24. Get the full timeline:
Most recent: Clinical Trial Update: Exploratory Study Evaluating the Relevance of [68Ga]Ga-FAPI-46 for Staging and Identifying Progressing Patients With Transthyretin Cardiac Amyloidosis [Phase 2]